Managing Director and Chief Executive Officer
Tigenix
Czech Republic
Eduardo Bravo is currently working as an eminent member at TiGenix in Czech Republic. He has published numerous research papers and articles in reputed journals and has various other achievements in the related studies. He has extended his/her valuable service towards the scientific community with his extensive research work.
Anti-inflammatory, inflammatory, autoimmune and cardiac diseases. Two proprietary platforms of adipose-derived (eASC) and cardiac stem cells (CSC)